GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization - Top-Institutions - MDSpire

GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization

  • By

  • Aditya Mahadevan

  • Aidan Vosooghi

  • Jagmeet S Arora

  • Ruthvik Sunil Kumar

  • Gagandeep Singh

  • Katy K Tsai

  • Zoe Quandt

  • January 2, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Endocrinology
    • Translational Medicine

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Oncology
    • Endocrinology
    • Clinical Research

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Metabolic Disease Research

  • #4

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Oncology
    • Endocrinology
    • Clinical Pharmacology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Oncology
    • Endocrinology
    • Clinical Trials

Original Source(s)

GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization

  • by Aditya Mahadevan, Aidan Vosooghi, Jagmeet S Arora, Ruthvik Sunil Kumar, Gagandeep Singh, Katy K Tsai, Zoe Quandt

  • January 2, 2026

Related Content

From risk factors to molecular targets: clinical associations and molecular docking insights into phthalate-associated diabetic retinopathy

Severe IL-6–dominant immune-mediated inflammatory response complicated by probable arginine vasopressin deficiency following ivonescimab-based therapy in advanced EGFR-mutant lung squamous cell carcinoma: a case report

Growth hormone therapy after hematopoietic cell transplantation in childhood: a nationwide survey and longitudinal cohort study